Evidence map›Paper›PMID 32400087›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2020

Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"

Olivia S Kates, Cynthia E Fisher, Robert M Rakita, Jorge D Reyes, Ajit P Limaye

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  8. Review
  9. Organ transplantation using COVID-19-positive deceased donors.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  10. Liver transplantation from active COVID-19 donors: Is it ethically justifiable?Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Article
  11. Successful kidney transplantation from a deceased donor with severe COVID-19 respiratory illness with undetectable SARS-CoV-2 in donor kidney and aorta.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  12. Article
  13. Organ Transplantation Preparations During the COVID-19 Pandemic.Florence Nightingale journal of nursing · 2022
    Article
  14. COVID-19 and liver diseases.Egyptian liver journal · 2022
    Review
  15. Review
  16. Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping?American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Olivia S KatesDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-4381-0049
Cynthia E FisherDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Robert M RakitaDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-8105-8455
Jorge D ReyesDivision of Transplant Surgery, University of Washington, Seattle, Washington, USA.
Ajit P LimayeDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
University of Washington · US

Funding

Training Program in Infectious Diseases in the Immunocompromised HostT32AI118690 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2016 to 2025
$4.0M
Respiratory Viral Determinants of Chronic Lung Allograft DysfunctionK23HL143050 · NHLBI · UNIVERSITY OF WASHINGTON · PI FISHER, CYNTHIA E · 2018 to 2022
$986k
NHLBI NIH HHS K23 HL143050NIAID NIH HHS T32 AI118690
6 · The paper itself

Abstract

In the context of a rapidly evolving pandemic, multiple organizations have released guidelines stating that all organs from potential deceased donors with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection should be deferred, including from otherwise medically eligible donors found to have mild or asymptomatic SARS-CoV-2 discovered on routine donor screening. In this article, we critically examine the available data on the risk of transmission of SARS-CoV-2 through organ transplantation. The isolation of SARS-CoV-2 from nonlung clinical specimens, the detection of SARS-CoV-2 in autopsy specimens, previous experience with the related coronaviruses SARS-CoV and MERS-CoV, and the vast experience with other common RNA respiratory viruses are all addressed. Taken together, these data provide little evidence to suggest the presence of intact transmissible SARS-CoV in organs that can potentially be transplanted, specifically liver and heart. Other considerations including ethical, financial, societal, and logistical concerns are also addressed. We conclude that, for selected patients with high waitlist mortality, transplant programs should consider accepting heart or liver transplants from deceased donors with SARS-CoV-2 infection.

Indexed as

Tissue DonorsBetacoronavirusCoronavirus InfectionsCOVID-19Ethics, MedicalHeartHeart TransplantationHumansLiverLiver TransplantationLungOccupational ExposurePandemicsPneumonia, ViralSARS-CoV-2Severe Acute Respiratory Syndromedonors and donation: deceaseddonors and donation: donor-derived infectionseditorial/personal viewpointethicsethics and public policyinfection and infectious agents - viralinfectious diseaseorgan acceptanceorgan procurement and allocationorgan transplantation in general

Identifiers

PMID32400087
PMCPMC7272824
OpenAlexW3024441519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.